A Phase 1 study of oral gallium maltolate in relapsed glioblastoma
Active, Not Recruiting Phase 1 NCT04319276
Study Description
A study to evaluate the safety and preliminary effectiveness of an investigational drug called gallium maltolate in patients with recurrent glioblastoma brain tumor
Study Details
- Registry ID:
- NCT04319276
- Conditions:
- Glioblastoma
- Phase:
- Phase 1
- Target Enrollment:
- 26 participants
- Start Date:
- Healthy Volunteers:
- No
Study Locations (1 site)
-
Froedtert Hospital & the Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.